NanoString Technologies Inc (OQ:NSTG)

Business Focus: Medical Equipment, Supplies & Distribution

Jan 10, 2021 03:00 pm ET
NanoString Provides Preliminary Financial and Operational Highlights for Fourth Quarter and FY 2020
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today reported preliminary financial and operational highlights for the fourth quarter and fiscal year ended December 31, 2020.
Jan 06, 2021 12:14 pm ET
Nature Methods Selects Spatially-Resolved Transcriptomics as the Method of the Year for 2020
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that the journal Nature Methods has selected spatially-resolved transcriptomics as their prestigious Method of the Year for 2020. See article here:
Jan 04, 2021 04:01 pm ET
NanoString to Present at the 39th Annual J.P. Morgan Healthcare Conference
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that the company’s management is scheduled to present at the 39th Annual J.P. Morgan Virtual Healthcare Conference.
Dec 09, 2020 06:00 am ET
NanoString’s GeoMx Digital Spatial Profiler Identifies Diverse Immune Responses Within COVID-19 Patients in Study Published in Nature Communications
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced the publication of a new peer-reviewed study utilizing its GeoMx® Digital Spatial Profiler (DSP) platform to uncover new information in patients’ responses to SARS-CoV-2 infection. The study published in Nature Communications titled, “Temporal and Spatial Heterogeneity of Host Response to SARS-CoV-2 Pulmonary Infection,” revealed the spatial heterogeneity of patients’ immune responses based on GeoMx DSP profiling of active SARS-CoV-2 infection in the l
Dec 01, 2020 06:00 am ET
NanoString Unveils Spatial Molecular Imaging Platform, Complementing GeoMx DSP to Provide Compelling Product Roadmap for Spatial Biology
The spatial molecular imager combines the power of high-plex profiling with high-resolution imaging to enable the analysis of hundreds to thousands of RNAs or proteins directly from single cells within morphologically intact tissue samples. The platform utilizes the company’s advanced Hyb & Seq chemistry, which over the last 18 months has been optimized for in situ spatial analysis. The platform is capable of profiling RNA and protein within a single cell down to sub-cellular resolution in multiple tissue types. To date, prototype systems have imaged RNA from as many as 1,000+ genes simultaneo
Nov 18, 2020 04:01 pm ET
NanoString to Host Virtual Investor and Analyst Day on December 1st, 2020
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that it will host an Investor and Analyst Day on Tuesday, December 1st. The event is scheduled to take place from 11:30am – 1:30pm Eastern time and will be conducted in a virtual format.
Nov 17, 2020 06:00 am ET
NanoString and Oregon Health & Science University Announce Collaboration to Develop GeoMx-Based Spatial Profiling Assays for Breast Cancer
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced a collaboration with Oregon Health & Science University (OHSU) for their development of novel GeoMx® Digital Spatial Profiler (DSP) protein assays to spatially profile breast cancer. These assays will be designed to enhance breast cancer tumor analysis and may inform clinical decision-making of patient treatment options. The work will be performed under the GeoMx Translational Leadership Network (GTLN), and the newly formed GeoMx Clinical Consortium, w
Nov 12, 2020 04:01 pm ET
NanoString to Present at the Stifel 2020 Virtual Healthcare Conference
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that the company’s management is scheduled to present at the Stifel 2020 Virtual Healthcare Conference.
Nov 11, 2020 06:00 am ET
NanoString Highlights Growing Body of Spatial Biology Research Presented at the 35th Annual Meeting of the Society of Immunotherapy of Cancer Conference (SITC)
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced the highlights of more than 35 NanoString-related abstracts, including 11 spatial biology studies that used the GeoMx® Digital Spatial Profiler (DSP), which will be presented at the SITC 35th Annual Meeting.
Nov 09, 2020 04:01 pm ET
NanoString Technologies Releases Operating Results for Third Quarter of 2020
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today reported financial results for the third quarter of 2020.
Nov 09, 2020 06:00 am ET
NanoString Launches GeoMx DSP Protein Assays for Next Generation Sequencing
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced the launch of GeoMx® DSP Protein Assays for next generation sequencing (NGS) readout, enabling multi-analyte analysis for both nCounter® and NGS readout.
Nov 06, 2020 04:01 pm ET
NanoString to Present at the 29th Annual Credit Suisse Healthcare Conference
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that the company’s management is scheduled to present at the 29th Annual Credit Suisse Healthcare Conference which is being held virtually.
Oct 13, 2020 04:01 pm ET
NanoString Technologies Announces Closing of Public Offering of $230.0 Million of Common Stock Including Exercise in Full of Option to Purchase Additional Shares
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced the closing of its previously announced underwritten public offering of 5,750,000 shares of its common stock at a price to the public of $40.00 per share pursuant to its existing shelf registration statement, for gross proceeds of $230.0 million. The number of shares issued at closing included the exercise in full of the underwriters’ option to purchase 750,000 additional shares. Net proceeds to NanoString from the offering were approximately $215.7 mi
Oct 08, 2020 09:33 am ET
OnRamp Bio and NanoString Announce Global Availability of ROSALIND® for nCounter Users
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, and OnRamp Bioinformatics, a provider of cloud-based genomic analysis tools, today announced a key milestone in their partnership to develop new analysis tools to accelerate research on NanoString’s nCounter® Analysis System. After successful completion of an Early Access Program announced in May, the parties are expanding access to new analysis capabilities to all nCounter users. The new analysis functionality is built into
Oct 07, 2020 07:58 pm ET
NanoString Technologies Announces Pricing of Upsized Public Offering of $200 Million of Common Stock
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced the pricing of an upsized underwritten public offering of 5,000,000 shares of its common stock at a price to the public of $40.00 per share pursuant to its existing shelf registration statement, for gross proceeds of $200.0 million. The size of the offering was increased from the previously announced $150.0 million of shares of common stock offered. NanoString has granted to the underwriters of the offering a 30-day option to purchase up to an addition
Oct 06, 2020 04:18 pm ET
NanoString Technologies Announces Commencement of Public Offering of Common Stock
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that it intends to offer and sell, subject to market and other conditions, $150.0 million of shares of its common stock in an underwritten public offering pursuant to NanoString’s shelf registration statement. In connection with this offering, NanoString expects to grant the underwriters a 30-day option to purchase up to $22.5 million of additional shares of its common stock. NanoString intends to use the net proceeds of the offering for working capita
Oct 06, 2020 04:06 pm ET
NanoString Technologies Provides Preliminary Financial and Operational Highlights for Third Quarter 2020
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today provided preliminary financial and operational highlights for the third quarter of 2020.
Oct 05, 2020 06:00 am ET
NanoString to Release Third Quarter 2020 Operating Results and Host Conference Call on Monday, November 9, 2020
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that the Company will release third quarter 2020 operating results after the close of the market on Monday, November 9, 2020. Company management will host a conference call beginning at 4:30pm ET to discuss those results and provide a business update.
Sep 14, 2020 06:00 am ET
NanoString Launches Whole Transcriptome Atlas under GeoMx Technology Access Program and Names First GeoMx Premier Access Sites
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced the establishment of the GeoMx Premier Access Sites, a global service network that will provide access to the GeoMx Cancer Transcriptome Atlas and future GeoMx commercial assays. The company also announced the availability of the new GeoMx Whole Transcriptome Atlas through the Technology Access Program (TAP) for the GeoMx Digital Spatial Profiler (DSP). Together these initiatives provide expanded access to next generation sequencing readout on GeoMx DS
Sep 09, 2020 04:01 pm ET
NanoString to Present at the 18th Annual Morgan Stanley Global Healthcare Conference
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that the company’s management is scheduled to present at the Morgan Stanley Global Healthcare Conference.
Sep 09, 2020 06:00 am ET
NanoString Announces New GeoMx COVID-19 Consortium, Part of the GeoMx Translational Leadership Network
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced the formation of the GeoMx Translational Leadership Network (GTLN). The GTLN will pioneer the application of spatial biology in large translational research studies, developing and sharing standardized practices to facilitate collaboration between groups of researchers across multiple institutions. To date, the GTLN includes members of the GeoMx Breast Cancer Consortium, established in 2019, and the newly established GeoMx COVID-19 Consortium. NanoStri
Sep 03, 2020 04:01 pm ET
NanoString to Present at the 2020 Baird Global Healthcare Conference
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that the company’s management is scheduled to present at the 2020 Baird Global Healthcare Conference.
Aug 10, 2020 04:01 pm ET
NanoString Technologies Releases Operating Results for Second Quarter of 2020
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today reported financial results for the second quarter of 2020.
Aug 06, 2020 06:00 am ET
Bio-Techne And NanoString Announce Offering Of RNAscope Reagents Validated For Use With The GeoMx Digital Spatial Profiler
MINNEAPOLIS and SEATTLE, Aug. 6, 2020 /PRNewswire/ -- Bio-Techne (NASDAQ:TECH), a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic markets and NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced an expansion of their partnership to include compatibility with ACD's 21,000+ RNAscope probes and 10 qualified RNAscope probe combinations with GeoMx® Digital Spatial Profiler (DSP) and the recently launched GeoMx Cancer Transcriptome Atlas...
Aug 06, 2020 06:00 am ET
NanoString and Bio-Techne Announce Offering of RNAscope Reagents Validated for Use With the GeoMx Digital Spatial Profiler
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, and Bio-Techne (NASDAQ:TECH), a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic markets, today announced an expansion of their partnership to include compatibility with ACD’s 21,000+ RNAscope probes and 10 qualified RNAscope probe combinations with the GeoMx® Digital Spatial Profiler (DSP) and the recently launched GeoMx Cancer Transcriptome Atlas (CTA).
Aug 03, 2020 06:00 am ET
NanoString Extends Leadership in Spatial Genomics with Launch of GeoMx DSP Read-Out for Next Generation Sequencers
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced the commercial availability of the first GeoMx® Digital Spatial Profiler (DSP) product optimized for read-out on Next Generation Sequencing (NGS) technology from Illumina, the Cancer Transcriptome Atlas (CTA).
Jul 08, 2020 06:00 am ET
NanoString to Release Second Quarter 2020 Financial Results and Host Conference Call on Monday, August 10, 2020
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that the Company will release second quarter 2020 financial results after the close of the market on Monday, August 10, 2020. Company management will host a conference call beginning at 4:30pm ET to discuss those results and provide a business update.
Jun 16, 2020 05:41 pm ET
NanoString Announces New Products to Advance COVID-19 Disease Research
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced the availability of new solutions to study the immune response in COVID-19 disease research. As part of an expanding portfolio of infectious disease research solutions, the nCounter® Host Response Gene Expression Panel and COVID -19 Panel Plus spike-in provide a comprehensive analysis of the viral infection and immune response. New protein and RNA content available on the GeoMx® Digital Spatial Profiler enable high-plex analysis of key biological pathw
May 20, 2020 09:00 am ET
NanoString and OnRamp BioInformatics Partner to Develop Cloud-Based Analysis Solutions for nCounter Data
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, and OnRamp Bioinformatics, a provider of cloud-based genomic analysis tools, today announced a collaboration for the development of new analysis tools for data generated on NanoString’s nCounter® Analysis System. The new analysis functionality is built into
May 14, 2020 04:00 pm ET
NanoString to Present at the UBS Global Healthcare Conference
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that the company’s management is scheduled to present at the 2020 UBS Global Healthcare Conference.
May 12, 2020 06:00 am ET
Recent Publications Demonstrate the Performance of the GeoMx DSP and Establish New Standards for Spatial Profiling in Discovery & Translational Research
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today highlighted several recent peer-reviewed publications that utilized the company’s GeoMx® Digital Spatial Profiler (DSP) to discover spatially-resolved biomarkers. GeoMx DSP is an integrated system comprised of hardware, software, and reagents, capable of being read out using either the nCounter Analysis System or Next-Generation Sequencing (NGS).
May 11, 2020 06:00 am ET
NanoString to Present at the Bank of America Health Care Conference
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that the company’s management is scheduled to present at the 2020 Bank of America Securities Health Care Conference.
May 07, 2020 04:01 pm ET
NanoString Technologies Releases Operating Results for First Quarter of 2020
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today reported financial results for the first quarter of 2020.
Apr 15, 2020 09:00 am ET
Singapore Researchers Use NanoString’s nCounter Platform to Rapidly Profile the Response of the Immune System to the SARS-CoV-2 Virus
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced the first publication utilizing the nCounter® platform and its leading gene expression panels for measuring immune response in COVID-19 research. Work published in the journal Cell Host & Microbe by a team of scientists from the Viral Research and Experimental Medicine Centre (ViREMiCS), a unit of the SingHealth Duke-NUS Academic Medical Centre (AMC), outline the differences in host immune response to SARS-CoV-2 infections in their publication t
Apr 06, 2020 04:01 pm ET
NanoString Provides COVID-19 Business Update and Announces Conference Call on Thursday May 7th, 2020
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced preliminary operational and financial results for the quarter ended March 31, 2020, and outlined the company’s response to the COVID-19 pandemic and the ongoing impact on operations.
Mar 05, 2020 06:00 am ET
NanoString Technologies Announces Pricing of Upsized Offering of $200 Million of Convertible Senior Notes
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for translational research, today announced the pricing of $200 million aggregate principal amount of 2.625% convertible senior notes due 2025 in a private placement to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). NanoString also granted the initial purchasers of the notes a 13-day option to purchase up to an additional $30 million aggregate principal amount of the notes. The offering of the notes was upsized from the originally anno
Mar 04, 2020 07:21 am ET
NanoString Technologies Announces Proposed Private Offering of $175 Million of Convertible Senior Notes
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for translational research, today announced that it intends to offer, subject to market conditions and other factors, $175 million aggregate principal amount of convertible senior notes due 2025 in a private placement to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). NanoString also intends to grant the initial purchasers of the notes a 13-day option to purchase up to an additional $26.25 million aggregate principal amount of the notes
Feb 26, 2020 04:00 pm ET
NanoString Technologies Releases Fourth Quarter and Full Year 2019 Operating Results and Provides 2020 Financial Outlook
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for translational research, today reported financial results for the fourth quarter and year ended December 31, 2019.
Feb 20, 2020 06:00 am ET
NanoString Highlights Groundbreaking Spatial Genomics Research Using Expanding Portfolio of GeoMx High-Plex RNA Atlas Products at 2020 Advances in Genome Biology and Technology (AGBT) Conference
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced ten scientific studies utilizing the GeoMx™ Digital Spatial Profiler (DSP) that will be showcased at the 2020 Advances in the Genome Biology and Technology (AGBT) conference being held at the JW Marriott in Marco Island, Florida. These studies span cancer translational research to neuroscience discovery applications, illustrating the platform’s flexibility and opportunity to spatially map distinct cell types and quantitate biological activity. NanoStri
Feb 18, 2020 06:00 am ET
NanoString to Present at the 40th Annual Cowen Healthcare Conference
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for translational research, today announced that the company’s management is scheduled to present at the 40th Annual Cowen Healthcare Conference in Boston.
Feb 10, 2020 09:00 am ET
NanoString to Release Fourth Quarter and Fiscal Year 2019 Financial Results and Host Conference Call on Wednesday, February 26, 2020
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for translational research, today announced that the Company will release fourth quarter and fiscal year 2019 financial results after the close of the market on Wednesday, February 26, 2020. Company management will host a conference call beginning at 4:30pm ET to discuss those results and provide a business update.
Feb 06, 2020 08:00 am ET
Jounce Therapeutics Presents New Vopratelimab Predictive Biomarker Data Supporting Use in the Upcoming SELECT Trial at the 2020 ASCO-SITC Clinical Immuno-Oncology Symposium Annual Meeting and Announce
Jounce Therapeutics, Inc. (NASDAQ: JNCE), a clinical-stage company focused on the discovery and development of novel cancer immunotherapies and predictive biomarkers, today announced new data on the identification of the predictive biomarker to be...
Jan 15, 2020 01:28 pm ET
Two Landmark Nature Publications use NanoString’s GeoMx Digital Spatial Profiling to Dissect Mechanisms of Response to Immunotherapy
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for translational research, today announced the publication of two peer-reviewed studies using the GeoMx™ Digital Spatial Profiler (DSP) in the journal Nature. The two independent papers published by groups at the MD Anderson Cancer Center and Lund University used GeoMx DSP for deep molecular profiling of immune cells critical for understanding response to immunotherapy in patients with metastatic melanoma.
Jan 12, 2020 06:00 pm ET
NanoString Provides Preliminary Operational and Financial Results for Fourth Quarter and FY 2019
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for translational research, today provided preliminary operational and financial results for the fourth quarter and fiscal year ended December 31, 2019.
Jan 02, 2020 04:01 pm ET
NanoString to Present at the 38th Annual JP Morgan Healthcare Conference
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for translational research, today announced that the company’s management is scheduled to present at the 38th Annual JP Morgan Healthcare Conference in San Francisco.
Dec 11, 2019 06:00 am ET
NanoString Announces the Creation of the GeoMx Breast Cancer Consortium
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for translational research, today announced the formation of the GeoMx™ Breast Cancer Consortium (GBCC).
Dec 03, 2019 05:00 pm ET
NanoString Announces Exclusive License of nCounter Diagnostic Assets and Rights to Veracyte
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for translational research, today announced a strategic transaction to exclusively license select nCounter-based diagnostic assets and rights to Veracyte Inc. for $50 million in cash and Veracyte stock, plus up to $10 million in cash upon satisfaction of future potential milestones.
Dec 03, 2019 06:00 am ET
Nature Medicine Publication Highlights Use of NanoString’s Hyb & Seq Technology to Perform Rapid Genotypic and Phenotypic Antibiotic Susceptibility Testing
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for translational research and molecular diagnostic products, today announced the publication of a collaborative study with the Broad Institute of MIT and Harvard entitled “A rapid and accurate method to determine antibiotic susceptibilities based on simultaneous detection of genotype and phenotype” that demonstrates the potential for the Hyb & Seq™ technology to transform infectious disease testing. NanoString and the Broad Institute have entered into a non-exclusive license agreement for intellectual proper
Nov 25, 2019 04:01 pm ET
NanoString to Present at the Evercore ISI 2nd Annual HealthCONx Conference
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for translational research and molecular diagnostic products, today announced that the company’s management is scheduled to present at the Evercore ISI 2nd Annual HealthCONx Conference in Boston.
Nov 13, 2019 04:01 pm ET
NanoString to Present at the Stifel 2019 Healthcare Conference
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for translational research and molecular diagnostic products, today announced that the company’s management is scheduled to present at the Stifel 2019 Healthcare Conference in New York City.
Nov 07, 2019 04:01 pm ET
NanoString Highlights the Results of Research Presented at the 2019 Annual Meeting of the Society of Immunotherapy for Cancer (SITC)
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for translational research and molecular diagnostic products, today announced the highlights of numerous abstracts demonstrating advances in understanding of immune response and cancer immunotherapy using the nCounter® and GeoMx™ Digital Spatial Profiler (DSP) platforms that will be presented at the 34th Annual Meeting of the Society of Immunotherapy for Cancer (SITC).
Nov 04, 2019 04:01 pm ET
NanoString Technologies Releases Operating Results for Third Quarter of 2019
NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today reported financial results for the third quarter of 2019.
Nov 04, 2019 06:00 am ET
NanoString Announces Availability of the GeoMx Cancer Transcriptome Atlas Through the Technology Access Program for Digital Spatial Profiling
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for translational research and molecular diagnostic products, today announced the availability of its new GeoMx™ Cancer Transcriptome Atlas through the Technology Access Program (TAP) for the GeoMx Digital Spatial Profiler (DSP).
Nov 04, 2019 06:00 am ET
NanoString Technologies Supports the Human Cell Atlas (HCA) to Enable High-plex Spatial Analysis Across Discovery Programs
NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that it will support the Human Cell Atlas (HCA) initiative for high-plex, spatial quantitation of RNA and protein across a variety of tissue types. Under the terms of the agreement, HCA members and their insti
Oct 31, 2019 06:00 am ET
NanoString Appoints Don Kania, Ph.D. to its Board of Directors
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for translational research and molecular diagnostic products, today announced the appointment of Don Kania, Ph.D. to its board of directors, effective October 30, 2019.
Oct 07, 2019 04:05 pm ET
NanoString to Release Third Quarter 2019 Financial Results and Host Conference Call on Monday, November 4, 2019
NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that the Company will release third quarter 2019 financial results after the close of trading on Monday, November 4, 2019. Company management will host a conference call beginning at 4:30pm ET to discuss those results and provide a business update.
Oct 04, 2019 04:30 pm ET
NanoString Reports Inducement Grant Under NASDAQ Listing Rules
NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today reported, as required by NASDAQ Stock Market Rules, an equity inducement award to Mark Winham, the Company’s new Senior Vice President, Operations.
Oct 02, 2019 06:00 am ET
NanoString Appoints Mark Winham Senior Vice President of Operations
NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced the appointment of Mark Winham as senior vice president of Operations effective October 2, 2019.
Sep 24, 2019 08:00 am ET
CareDx Adds HistoMap To Testing Portfolio
CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, today announced a...
Sep 23, 2019 06:00 am ET
NanoString Introduces New Gene Expression Research Panel for Human Organ Transplantation
NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced the launch of a new gene expression panel for researchers to evaluate the human immune response following organ transplantation.
Aug 28, 2019 06:00 am ET
NanoString to Present at the 2019 Morgan Stanley Global Healthcare Conference
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for translational research and molecular diagnostic products, today announced that the company’s management is scheduled to present at the 2019 Morgan Stanley...
Aug 19, 2019 06:00 am ET
NanoString to Present at the Baird 2019 Global Healthcare Conference
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for translational research and molecular diagnostic products, today announced that the company’s management is scheduled to present at the Baird 2019 Global...
Aug 06, 2019 06:00 am ET
New Publication Demonstrates First Use of NanoString’s GeoMx Digital Spatial Profiler in Neuroscience
NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced the publication of a study in the journal Acta Neuropathologica that demonstrates the...
Jul 31, 2019 04:01 pm ET
NanoString Technologies Releases Operating Results for Second Quarter of 2019
NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today reported financial results for the second quarter of 2019. Second Quarter Financial Highlights Total...
Jul 30, 2019 09:29 am ET
NanoString Technologies and Mayo Clinic Laboratories Enter Joint Development Agreement to Develop Novel Assays
NanoString Technologies and Mayo Clinic Laboratories have announced a collaboration to develop clinical tests using NanoString's new GeoMx Digital Spatial Profiler. GeoMx combines spatial and molecular profiling technologies by generating a whole...
Jul 23, 2019 03:20 pm ET
CORRECTING and REPLACING - Nature Medicine Publication Highlights use of the GeoMx Digital Spatial Profiler to Characterize Mechanism of Neurotoxicity in Immuno-Therapy
In a release issued yesterday by NanoString Technologies, Inc. (NASDAQ:NSTG) under the same headline, please note that in the third paragraph Dr. Justin Balko's title has been revised. Complete corrected text follows:  NanoString Technologies,...
Jul 22, 2019 04:01 pm ET
Nature Medicine Publication Highlights use of the GeoMx Digital Spatial Profiler to Characterize Mechanism of Neurotoxicity in Immuno-Therapy
NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced the publication of a study in the journal Nature Medicine that demonstrates the capability...
Jul 15, 2019 06:00 am ET
NanoString Collaborates with MODEL-AD Consortium to Accelerate Alzheimer’s Disease Research
NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced a collaboration with the MODEL-AD consortium that has resulted in the development of two...
Jul 10, 2019 06:00 am ET
NanoString to Release Second Quarter 2019 Financial Results and Host Conference Call on Wednesday, July 31, 2019
NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that the Company will release second quarter 2019 financial results after the close of...
Jun 18, 2019 04:01 pm ET
Publication in the Journal Clinical Cancer Research Uses NanoString’s GeoMx Digital Spatial Profiler to Discover Predictive Biomarkers for Immunotherapy
NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced a publication in the journal Clinical Cancer Research of a collaborative research study led...
May 30, 2019 04:01 pm ET
NanoString Partners with Multiple Leading Contract Research Organizations to Provide Standardized PanCancer IO 360 Data Analysis Reports
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for translational research and molecular diagnostic products, today announced commercial partnerships with three Contract Research Organizations (CROs), including...
May 15, 2019 06:00 am ET
NanoString to Present at the UBS Global Healthcare Conference
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for translational research and molecular diagnostic products, today announced that the company’s management is scheduled to present at the UBS Global Healthcare...
May 09, 2019 04:01 pm ET
NanoString Technologies Releases Operating Results for First Quarter of 2019
NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today reported financial results for the first quarter of 2019. First Quarter Financial Highlights Total...
Apr 08, 2019 04:01 pm ET
NanoString to Release First Quarter 2019 Financial Results and Host Conference Call on Thursday, May 9, 2019
NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that the Company will release first quarter 2019 financial results after the close of...
Apr 04, 2019 05:00 am ET
Investor Expectations to Drive Momentum within Cisco, NanoString Technologies, Galapagos NV, A10 Networks, International Seaways, and Scholastic — Discovering Underlying Factors of Influence
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Cisco Systems, Inc. (NASDAQ:CSCO), NanoString Technologies, Inc....
Apr 02, 2019 09:17 am ET
NanoString and Leica Biosystems to Co-Market GeoMx Digital Spatial Profiling and Leica’s BOND RX Platforms for High Throughput Spatial Analysis
NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced a comarketing agreement to promote and provide technical support for a research workflow...
Apr 01, 2019 06:00 am ET
NanoString and Abcam Enter Commercial Partnership to Provide Expanded Menu of Antibodies for GeoMx Digital Spatial Profiler
NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced a commercial agreement with Abcam plc (AIM:ABC), a global innovator in life science reagents...
Mar 28, 2019 09:09 am ET
Bio-Techne and NanoString Partner to Co-Develop Integrated Workflow for RNA Spatial Profiling
MINNEAPOLIS, March 28, 2019 /PRNewswire/ -- Bio-Techne (NASDAQ:TECH), a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities, and NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, are partnering to accelerate the development of new tools for spatial genomics. The combined workflow that unites the RNAscope® reagent portfolio from Bio-Techne with NanoString's GeoMx™ RNA Assays enables researchers to molecularly guide their high...
Mar 28, 2019 06:00 am ET
Bio-Techne and NanoString Partner to Co-Develop Integrated Workflow for RNA Spatial Profiling
Bio-Techne (NASDAQ:TECH), a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities, and NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for...
Mar 27, 2019 06:00 am ET
NanoString Announces Commercial Launch of GeoMx Digital Spatial Profiler at the 2019 American Association of Cancer Research Conference
NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced the commercial availability of the GeoMx™ Digital Spatial Profiler during the American...
Mar 26, 2019 06:00 am ET
NanoString Highlights Record Number of nCounter and GeoMx Research Studies at 2019 American Association of Cancer Research (AACR) Conference
NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that a record number of studies enabled by the company’s nCounter® Analysis System and...
Mar 25, 2019 06:00 am ET
NanoString Technologies Announces Closing of Public Offering of 5,175,000 Shares of Common Stock Including Exercise in Full of Option to Purchase Additional Shares
NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced the closing of its previously announced underwritten public offering of 5,175,000 shares of...
Mar 19, 2019 06:33 pm ET
NanoString Technologies Announces Pricing of Public Offering of 4,500,000 Shares of Common Stock
NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced the pricing of an underwritten public offering of 4,500,000 shares of its common stock at a...
Mar 18, 2019 04:18 pm ET
NanoString Technologies Announces Commencement of Public Offering of Common Stock
NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced an underwritten public offering of 4,500,000 shares of its common stock pursuant to its...
Mar 07, 2019 04:01 pm ET
NanoString Technologies Releases Fourth Quarter and Full Year 2018 Operating Results and Provides 2019 Outlook
NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today reported financial results for the fourth quarter and year ended December 31, 2018. Fourth Quarter...
Mar 04, 2019 04:01 pm ET
NanoString to Present at the 39th Annual Cowen Healthcare Conference
NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that the company’s management is scheduled to present at the 39th Annual Cowen Healthcare...
Feb 27, 2019 07:10 am ET
Factors of Influence in 2019, Key Indicators and Opportunity within Wayfair, Valero Energy, Barrick Gold, U.S. Silica, NanoString Technologies, and Pzena Investment Management — New Research Emphasize
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Wayfair Inc. (NYSE:W), Valero Energy Corporation (NYSE:VLO), Barrick Gold...
Feb 27, 2019 06:00 am ET
NanoString Showcases GeoMx and Hyb & Seq Platforms at 2019 Advances in Genome Biology and Technology (AGBT) Conference
NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced a wave of studies demonstrating the power and potential of its two major pipeline products....
Feb 25, 2019 06:00 am ET
NanoString to Host Inaugural Spatial Genomics Summit on Wednesday, February 27th at the 2019 Advances in Genome Biology and Technology (AGBT) Conference
NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that the company will be hosting a Spatial Genomics Summit at the 2019 Advances in Genome...
Feb 21, 2019 09:00 am ET
NanoString to Release Fourth Quarter and Fiscal Year 2018 Financial Results and Host Conference Call on Thursday, March 7, 2019
NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that the Company will release fourth quarter and fiscal year 2018 financial results after...
Jan 06, 2019 08:00 pm ET
NanoString Technologies Provides Preliminary Operational and Financial Results for Fourth Quarter and Fiscal Year 2018
NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today provided preliminary operational and financial results for the fourth quarter and fiscal year ended...
Dec 21, 2018 07:00 am ET
NanoString to Present at the 37th Annual J.P. Morgan Healthcare Conference
NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that the company’s management is scheduled to present at the 37th Annual J.P. Morgan...
Dec 19, 2018 04:01 pm ET
United Kingdom’s National Institute for Health and Care Excellence (NICE) Recommends NanoString’s Prosigna Breast Cancer Gene Signature Assay to Guide Chemotherapy Treatment Decisions for Qualified Ea
NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that health officials from the National Institute for Health and Care Excellence (NICE) in...
Dec 04, 2018 07:25 am ET
Detailed Research: Economic Perspectives on NanoString Technologies, Tyson Foods, Welbilt, Immune Design, Turning Point Brands, and LGI Homes — What Drives Growth in Today's Competitive Landscape
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of NanoString Technologies, Inc. (NASDAQ:NSTG), Tyson Foods, Inc. (NYSE:TSN),...
Nov 29, 2018 06:00 am ET
NanoString Technologies Highlights Advances in Precision Oncology at the 60th Annual Meeting of the American Society of Hematology
NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced the highlights of more than 40 nCounter®-based research abstracts that will be presented at...
Nov 20, 2018 06:00 am ET
NanoString to Present at the Evercore ISI HEALTHCONx Conference
NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that the company’s management is scheduled to present at the 2018 Evercore ISI HEALTHCONx...
Nov 08, 2018 04:01 pm ET
NanoString Technologies Releases Operating Results for Third Quarter of 2018
NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today reported financial results for the third quarter of 2018. Third Quarter Financial Highlights Total...
Nov 08, 2018 06:00 am ET
NanoString Announces Launch of CAR-T Characterization Panel for use in Development and Manufacturing
NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced the launch of a new gene expression panel for the molecular characterization of CAR-T cells...
Nov 07, 2018 04:09 pm ET
NanoString Highlights Research Presented at the 2018 Annual Meeting of the Society of Immunotherapy for Cancer (SITC)
NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced the highlights of numerous advances in understanding of immune response and cancer...
Nov 05, 2018 06:00 am ET
NanoString to Present at the 2018 Canaccord Medical Technologies and Diagnostics Forum
NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that the company’s management is scheduled to present at the 2018 Canaccord Medical...
Oct 30, 2018 06:00 am ET
NanoString Highlights Advances in Product Pipeline and Application Development at the 2018 Association of Molecular Pathology Conference
NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today highlighted advances in product development that will be presented at the Association of Molecular...
Oct 29, 2018 06:00 am ET
MacroGenics and NanoString Enter Translational Research Collaboration to Identify and Develop Biomarkers in Immuno-Oncology
NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that MacroGenics (NASDAQ:MGNX) and NanoString have entered into a translational research...
Oct 25, 2018 09:25 am ET
Recent Analysis Shows PennyMac Mortgage Investment Trust, Amicus Therapeutics, Children's Place, PLDT, NanoString Technologies, and Worthington Industries Market Influences — Renewed Outlook, Key Driv
In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of PennyMac Mortgage Investment Trust (NYSE:PMT), Amicus Therapeutics,...
Oct 15, 2018 09:00 am ET
NanoString Announces $100 Million Term Loan Facility with CRG
NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that it has entered into a new $100 million term loan facility with the CR Group L.P. (CRG),...
Oct 08, 2018 04:01 pm ET
Landmark Publications in Nature Medicine use NanoString’s Digital Spatial Profiling Platform to Discover Novel Insights in Immuno-Oncology
NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that the first peer-reviewed publications using the GeoMx™ Digital Spatial Profiler have...
Oct 08, 2018 06:01 am ET
NanoString to Release Third Quarter 2018 Financial Results and Host Conference Call on Thursday, November 8, 2018
NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that the Company will release third quarter 2018 financial results after the close of...
Oct 04, 2018 04:01 pm ET
NanoString Announces the University of Oxford Selected as the Winning Recipient in GeoMx Digital Spatial Profiler Grant Program
NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that the University of Oxford has been selected as the winning recipient of a grant for a...
Sep 25, 2018 07:45 am ET
Consolidated Research: 2018 Summary Expectations for PLDT, Fidus Investment, NanoString Technologies, Maximus, Prologis, and SailPoint Technologies — Fundamental Analysis, Key Performance Indications
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of PLDT Inc. (NYSE:PHI), Fidus Investment Corporation (NASDAQ:FDUS),...
Sep 10, 2018 06:00 am ET
NanoString to Present at the Morgan Stanley Global Healthcare Conference
NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that the company’s management is scheduled to present at the 2018 Morgan Stanley Global...
Sep 05, 2018 06:00 am ET
NanoString Launches Priority Site Program for New GeoMx Digital Spatial Profiler
NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced the launch of the GeoMx™ Priority Site (GPS) program to satisfy the strong demand for the...
Aug 22, 2018 04:01 pm ET
NanoString to Present at the Baird 2018 Global Healthcare Conference
NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that the company’s management is scheduled to present at the Baird 2018 Global Healthcare...
Aug 13, 2018 04:01 pm ET
NanoString Technologies Announces Exercise of Underwriters’ Option to Purchase Additional Shares of Common Stock
NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that the underwriters of its previously announced underwritten public offering have...
Aug 07, 2018 04:01 pm ET
NanoString Technologies Releases Operating Results for Second Quarter of 2018
NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today reported financial results for the second quarter of 2018. Second Quarter Financial Highlights...
Aug 07, 2018 06:01 am ET
NanoString Expands Centers of Excellence Program and Initiates Early Access Launch for Digital Spatial Profiling
NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that the company has added two new Centers of Excellence (COE) for NanoString’s Digital...
Jul 31, 2018 07:50 am ET
Investor Expectations to Drive Momentum within Builders FirstSource, NanoString Technologies, Polaris Industries, Navient, NIKE, and New Oriental Education & Technology Group — Discovering Underlying
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Builders FirstSource, Inc. (NASDAQ:BLDR), NanoString Technologies, Inc....
Jul 23, 2018 04:01 pm ET
NanoString Technologies Announces Closing of Public Offering of 4,000,000 Shares of Common Stock
NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced the closing of its previously announced underwritten public offering of 4,000,000 shares of...
Jul 17, 2018 06:40 pm ET
NanoString Technologies Announces Pricing of Public Offering of 4,000,000 Shares of Common Stock
NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced the pricing of an underwritten public offering of 4,000,000 shares of its common stock at a...
Jul 16, 2018 04:15 pm ET
NanoString Technologies Announces Commencement of Public Offering of Common Stock
NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that it intends to offer and sell, subject to market and other conditions, $50 million of...
Jul 16, 2018 04:14 pm ET
NanoString Technologies Provides Preliminary Revenue Results for Second Quarter 2018
NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today provided preliminary financial results for the quarter ended June 30, 2018. Financial Operational...
Jul 09, 2018 06:00 am ET
NanoString to Release Second Quarter 2018 Financial Results and Host Conference Call on Tuesday, August 7, 2018
NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that the Company will release second quarter 2018 financial results after the close of...
Jun 18, 2018 08:57 am ET
NanoString Establishes Netherlands Cancer Institute as a Center of Excellence for Digital Spatial Profiling
NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that the Netherlands Cancer Institute will become the first in a series of Centers of...
Jun 04, 2018 06:00 am ET
NanoString Announces Collaboration with National Cancer Institute to Improve Cancer Immunotherapy Biomarker Discovery
NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced a collaboration with the Cancer Therapy Evaluation Program (CTEP) of the National Cancer...
May 31, 2018 06:00 am ET
NanoString Highlights Record Number of nCounter-Based Abstracts at the 2018 Annual Meeting of the American Society of Clinical Oncology
NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today highlighted a record number of abstracts that will be presented at the American Society of Clinical...
May 15, 2018 04:01 pm ET
NanoString to Present at the 2018 UBS Global Health Care Conference
NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that the company’s management is scheduled to present at the 2018 UBS Global Heath Care...
May 08, 2018 04:01 pm ET
NanoString Technologies Releases Operating Results for First Quarter of 2018
NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today reported financial results for the first quarter of 2018. First Quarter Financial Highlights Total...
May 02, 2018 06:00 am ET
NanoString to Present at the Bank of America Merrill Lynch 2018 Health Care Conference
SEATTLE, May 02, 2018 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that the company’s management is scheduled to present at the Bank of...
Apr 30, 2018 06:00 am ET
NanoString Partners with Multiple Leading Contract Research Organizations to Market Digital Spatial Profiling Service
Expanded Technology Access Program Responds to Interest from Leading Biopharmaceutical Companies and Lab Service Providers
Apr 18, 2018 07:35 am ET
Investor Expectations to Drive Momentum within Casella Waste, Prologis, Flushing Financial, AMERISAFE, Aclaris Therapeutics, and NanoString Technologies — Discovering Underlying Factors of Influence
NEW YORK, April 18, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Casella Waste Systems, Inc. (NASDAQ:CWST), Prologis,...
Apr 12, 2018 06:00 am ET
NanoString Showcases Groundbreaking Body of Research at the 2018 Annual Meeting of the American Association for Cancer Research
More than 50 abstracts highlight the diverse capabilities of NanoString’s technology from gene expression profiling to Digital Spatial Profiling
Apr 10, 2018 04:01 pm ET
NanoString Announces Launch of Breast Cancer 360 Research Panel, Expanding the 360 Series of Cancer Panels for Translational Research and Signature Development
SEATTLE, April 10, 2018 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced the launch of the Breast Cancer 360™ (BC 360) research panel. The...
Apr 09, 2018 06:00 am ET
NanoString to Release First Quarter 2018 Financial Results and Host Conference Call on Tuesday, May 8, 2018
SEATTLE, April 09, 2018 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that the Company will release first quarter 2018 financial results after the...
Mar 29, 2018 07:45 am ET
New Research: Key Drivers of Growth for Bio-Techne, QTS Realty Trust, CYS Investments, Prologis, Gramercy Property Trust, and NanoString Technologies — Factors of Influence, Major Initiatives and Sust
NEW YORK, March 29, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Bio-Techne Corp (NASDAQ:TECH), QTS Realty Trust,...
Mar 07, 2018 04:01 pm ET
NanoString Technologies Releases Fourth Quarter and Full Year 2017 Operating Results and Provides 2018 Outlook
SEATTLE, March 07, 2018 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today reported financial results for the fourth quarter and year ended December 31, 2017.
Mar 06, 2018 04:05 pm ET
NanoString to Present at the 38th Annual Cowen Healthcare Conference
SEATTLE, March 06, 2018 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that the company’s management is scheduled to present at the 38th Annual...
Feb 21, 2018 06:00 am ET
NanoString Technologies to Release Fourth Quarter and Fiscal Year 2017 Financial Results and Host Conference Call on Wednesday, March 7, 2018
SEATTLE, Feb. 21, 2018 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that the Company will release fourth quarter and fiscal year 2017 financial...
Feb 12, 2018 06:00 am ET
NanoString Showcases Groundbreaking New Platforms at 2018 Advances in Genome Biology and Technology (AGBT) Conference
Digital Spatial Profiling Demonstrates Profiling of Proteins and 1,000+ mRNAs Across Multiple Regions from FFPE Tissue Sections using Next Generation Sequencing Readout
Feb 05, 2018 04:01 pm ET
NanoString Announces Largest and Most Comprehensive Study to Date of Prosigna Breast Cancer Assay Published in Journal of Clinical Oncology
Comprehensive Study Includes All Danish Women Diagnosed with Breast Cancer from 2000 to 2003 who were Indicated for Prosigna and Treated with Endocrine Therapy
Jan 26, 2018 07:45 am ET
New Research: Key Drivers of Growth for NanoString Technologies, Oaktree Capital Group, Midstates Petroleum, GlycoMimetics, State Street, and Retail Properties of America — Factors of Influence, Major
NEW YORK, Jan. 26, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of NanoString Technologies, Inc. (NASDAQ:NSTG), Oaktree Capital...
Jan 19, 2018 09:18 pm ET
NanoString Reports Inducement Grant Under NASDAQ Listing Rules
SEATTLE, Jan. 19, 2018 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today reported, as required by NASDAQ Stock Market Rules, equity inducement awards to Thomas...
Jan 16, 2018 09:00 am ET
NanoString Appoints Thomas Bailey as Chief Financial Officer
SEATTLE, Jan. 16, 2018 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that Thomas Bailey has been appointed chief financial officer, effective January 16,...
Jan 08, 2018 05:00 am ET
NanoString Technologies Provides Preliminary Operational and Financial Results for Fourth Quarter and Fiscal Year 2017
Fourth Quarter Product and Service Revenue Exceeds High End of Company Guidance
Jan 04, 2018 06:00 am ET
NanoString and RikenGenesis Announce Partnership to Commercialize nCounter-Based Diagnostic Assays in Japan
NanoString and Riken Genesis, a subsidiary of Sysmex, partner to register and commercialize NanoString’s Lymphoma Subtyping Test for diagnostic use in Japan
Dec 07, 2017 04:00 pm ET
NanoString Technologies Highlights Advances in Precision Oncology at the 59th Annual Meeting of the American Society of Hematology
More than 45 Abstracts Highlight the Value of the nCounter Platform in Hematology, including 11 that Demonstrate the Potential Clinical Utility of the Lymphoma Subtyping Test
Nov 09, 2017 06:00 am ET
Nov 02, 2017 04:01 pm ET
NanoString Technologies Releases Operating Results for Third Quarter of 2017
SEATTLE, Nov. 02, 2017 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today reported financial results for the third quarter of 2017. The results were consistent...
Aug 31, 2017 04:00 pm ET
NanoString to Webcast Presentation at the 2017 Baird Global Healthcare Conference
SEATTLE, Aug. 31, 2017 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that it will webcast the company’s presentation at the 2017 Baird Global Healthcare Conference in New York City, on Thursday, September 7, 2017....
Aug 08, 2017 04:05 pm ET
NanoString and Lam Research Announce Strategic Development Collaboration to Advance Hyb & Seq Next Generation Sequencing Platform
SEATTLE and FREMONT, Calif., Aug. 08, 2017 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (Nasdaq:NSTG), a provider of life science tools for translational research and molecular diagnostic products, and Lam Research Corporation (Nasdaq:LRCX), a global supplier of innovative wafer fabrication equipment and services to the semiconductor industry, today announced a strategic collaboration to develop NanoString’s proprietary Hyb & Seq™ next-generation sequencing platform....
May 31, 2017 04:08 pm ET
NanoString Technologies Announces Offering of Common Stock
SEATTLE, May 31, 2017 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced an agreement to sell 2,750,000 shares of its common stock to Robert W. Baird & Co. Incorporated as the underwriter in an underwritten public offering pursuant to NanoString’s existing shelf registration statement. NanoString has also granted the underwriter a 30-day option to purchase up to an additional 412,500 shares of common stock. NanoString intends to use the net proceeds of the offering...
May 04, 2017 04:01 pm ET
NanoString Technologies Releases Operating Results for First Quarter of 2017
SEATTLE, May 04, 2017 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today reported financial results for the first quarter of 2017....
Mar 29, 2017 04:01 pm ET
NanoString Launches Multiple New Products at AACR 2017 to Advance Precision Oncology Research
SEATTLE, March 29, 2017 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, is releasing multiple new products at the American Association of Cancer Research (AACR) Meeting. The new products build on NanoString’s existing portfolio of products that leverage genomics and proteomics to advance precision oncology. ...
Mar 23, 2017 04:01 pm ET
NanoString Launches New PlexSet Technology as an Alternative to qPCR for Multiplexed High-Throughput Gene Expression Studies
SEATTLE, March 23, 2017 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced the commercial launch of nCounter® PlexSet™ reagents at the Association of Biomolecular Resource Facilities (ABRF) conference in San Diego, California.  These new reagents enable nCounter digital gene expression analysis that is more efficient and cost-effective than ever before for high-throughput projects....
Feb 22, 2017 04:01 pm ET
NanoString Technologies to Present at the Cowen and Company 37th Annual Health Care Conference
SEATTLE, Feb. 22, 2017 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that the company’s management is scheduled to present at the Cowen and Company 37th Annual Health Care Conference in Boston....
Jan 31, 2017 04:00 pm ET
Humana Issues Positive Coverage Decision for NanoString’s Prosigna® Breast Cancer Assay
SEATTLE, Jan. 31, 2017 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that Humana has issued a positive coverage decision for the Prosigna® Breast Cancer Gene Signature Assay. Humana and its more than 13 million members join other payors now covering Prosigna, collectively representing more than 175 million covered lives throughout the United States....
Dec 05, 2016 05:22 pm ET
NanoString Technologies Highlights Presentation of Multiple Prosigna/PAM50 and Immuno-Oncology Studies at the 39th Annual CTRC-AACR San Antonio Breast Cancer Symposium
SEATTLE, Dec. 05, 2016 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced advances in precision oncology using the Prosigna® Breast Cancer Gene Signature Assay and the PAM50 gene signature, the basis for Prosigna, will be presented at the 2016 CTRC-AACR San Antonio Breast Cancer Symposium (SABCS). In addition, numerous customers will be presenting data generated using NanoString’s nCounter® Analysis System, including several involving immuno-oncology....
Dec 01, 2016 04:00 pm ET
The Scientist Magazine Names NanoString Technologies nCounter Vantage 3D Panels a Top 10 Innovation of 2016
SEATTLE, Dec. 01, 2016 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that its nCounter Vantage 3D™ assays, a portfolio of panels that enable simultaneous analysis of DNA, RNA, and protein were listed by The Scientist as a Top 10 Innovation of 2016. Now in its ninth year, The Scientist top innovation award program recognizes new products revolutionizing life science research....
Nov 30, 2016 04:05 pm ET
NanoString Technologies Highlights Advances in Precision Oncology at the 58th Annual Meeting of the American Society of Hematology
SEATTLE, Nov. 30, 2016 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced the highlights of numerous advances in precision oncology and hematology using the nCounter® platform that will be presented at the Annual Meeting of the American Society of Hematology (ASH).  ...
Nov 10, 2016 04:01 pm ET
NanoString Technologies Teams with the OHSU Knight Cancer Institute to Develop Myeloid Gene Expression Panels to Advance Immuno-Oncology Research
In Special Recognition of the work of The Stand Up To Cancer-Lustgarten Foundation Pancreatic Dream Team and in honor of Pancreatic Cancer Awareness Month...
Nov 02, 2016 04:01 pm ET
NanoString Technologies Releases Operating Results for Third Quarter of 2016
SEATTLE, Nov. 02, 2016 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today reported financial results for the third quarter ended September 30, 2016....
Oct 19, 2016 06:00 am ET
NanoString Technologies Presents Update on Hyb & Seq™ Next-Generation Sequencing Chemistry at ASHG Annual Meeting
VANCOUVER, British Columbia, Oct. 19, 2016 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced an update on the company’s Hyb & Seq™ platform which is currently in development. Hyb & Seq is a library-free, amplification free single molecule sequencing technique that uses cyclic nucleic acid hybridization of fluorescent molecular barcodes onto native targets.  The Hyb & Seq chemistry was first described at the 2016 Advances in Genome Biology and Technology ...
Oct 18, 2016 06:00 am ET
NanoString Enhances Solid Tumor Profiling with 3D Biology Capabilities for Formalin-Fixed, Paraffin-Embedded (FFPE) Tissue Samples
SEATTLE, Oct. 18, 2016 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced the commercial launch of two new translational research assays in the company’s Vantage 3D product line at the American Society of Human Genetics (ASHG) Annual Meeting in Vancouver Canada:...
Sep 13, 2016 06:00 am ET
NanoString Technologies Appoints Kirk Malloy, Ph.D. to Board of Directors
SEATTLE, Sept. 13, 2016 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced the appointment of Kirk Malloy, Ph.D. to the company’s Board of Directors, effective September 12, 2016.  The Board now consists of seven members. ...
Aug 25, 2016 08:00 am ET
NanoString Technologies to Present at Two Upcoming Healthcare Conferences
SEATTLE, Aug. 25, 2016 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that the company’s management is scheduled to present at two upcoming conferences in September. Presenting at the conferences will be Brad Gray, Chief Executive Officer....
Aug 03, 2016 04:00 pm ET
NanoString Technologies Releases Operating Results for Second Quarter of 2016
Revenue Growth of 73% Year-Over-Year Driven by Strong nCounter SPRINT Demand, Robust Consumable Pull-Through and Achievement of Biopharma Collaboration Milestones...
Jul 07, 2016 04:00 pm ET
NanoString Technologies to Release Second Quarter 2016 Financial Results and Host Conference Call on Wednesday, August 3, 2016
SEATTLE, July 07, 2016 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that the Company will release second quarter 2016 financial results after the close of trading on Wednesday, August 3, 2016. Company management will host a conference call beginning at 4:30pm ET to discuss those results and provide a business update....
Jun 02, 2016 08:00 am ET
NanoString Technologies Highlights Advances in Precision Oncology and Immunotherapy at the 52nd Annual Meeting of the American Society of Clinical Oncology (ASCO)
SEATTLE, June 02, 2016 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced the highlights of numerous advances in precision oncology and immunotherapy using the nCounter® platform that will be presented at the Annual Meeting of the American Society of Clinical Oncology (ASCO).  ...
May 26, 2016 08:00 am ET
Cigna Issues Positive Coverage Decision for NanoString’s Prosigna® Breast Cancer Assay
SEATTLE, May 26, 2016 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of molecular diagnostic testing products and life science tools for translational research, today announced that Cigna has issued a positive Medical Coverage Policy decision for the Prosigna® Breast Cancer Gene Signature Assay.  Cigna and its roughly 13 million members join other payors now covering Prosigna, collectively representing more than 135 million covered lives throughout the United States....
May 24, 2016 08:00 am ET
NanoString Technologies to Present at the Jefferies 2016 Healthcare Conference
SEATTLE, May 24, 2016 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that the company’s management is scheduled to present at the Jefferies 2016 Healthcare Conference in New York, NY....
May 09, 2016 08:00 am ET
Aetna Issues Positive Coverage Decision for NanoString’s Prosigna® Breast Cancer Assay
SEATTLE, May 09, 2016 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of molecular diagnostic testing products and life science tools for translational research, today announced that Aetna has added the Prosigna® Breast Cancer Gene Signature Assay to its Tumor Markers Clinical Policy Bulletin.  Aetna and its more than 19 million members join other payors now covering Prosigna, collectively representing approximately 125 million covered lives throughout the United States....
May 05, 2016 04:00 pm ET
NanoString Technologies Releases Operating Results for First Quarter of 2016
SEATTLE, May 05, 2016 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today reported financial results for the first quarter ended March 31, 2016....
Apr 27, 2016 08:00 am ET
NanoString Technologies to Present at the Bank of America Merrill Lynch 2016 Health Care Conference
SEATTLE, April 27, 2016 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that the company’s management is scheduled to present at the Bank of America Merrill Lynch 2016 Health Care Conference in Las Vegas, NV....
Mar 14, 2016 11:15 am ET
Providence Health & Services and Institute for Systems Biology affiliate to catalyze scientific wellness
SEATTLE, March 14, 2016 /PRNewswire-USNewswire/ -- With the goal of bringing personalized medicine to every patient, Providence Health & Services and the Institute for Systems Biology announced today an affiliation that will transform health care to a proactive mode that is focused on keeping patients well and identifying the earliest opportunities to reverse or even prevent disease....

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please subscribe. Our packages start at $1.00 plus tax for the first month.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.